Performa HargaHarga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)84.82
Harga Terendah (52 Minggu)41.81
Latar Belakang Perusahaan
BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. The company is headquartered in Palo Alto, California.
Summary
Valuation Information
Current PE Ratio (TTM)-19.26
Forward PE Ratio-
Current Price to Book Value-6.18
Current Price to Sales23.93
EV to Revenue26.43
EV to EBITDA-9.4
PEG Ratio-
Per Share
Current EPS (Annualized)-3.74
Diluted EPS (TTM)-3.74
Revenue Per Share3.01
Current Book Value Per Share-11.64
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-498881984
Profit Margin-1.244
Operating Margin-0.545
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
